Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 2/20 | 0.39 |
| ▸ | TERT | O14746 | 1/20 | 0.33 |
| ▸ | CHKA | P35790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL179204 | 0.73 | APEX1 (0.64) | APEX1TERTCHKA | |
| SCHEMBL4946987 | 0.71 | CHKA (0.38) | APEX1TERTCHKA | |
| SCHEMBL1103773 | 0.65 | APEX1 (0.43) | APEX1TERT | |
| SCHEMBL19089065 | 0.65 | APEX1 (0.42) | APEX1TERTCHKA | |
| SCHEMBL21955684 | 0.65 | APEX1 (0.42) | APEX1TERTCHKA | |
| SCHEMBL16627792 | 0.64 | OXTR (0.40) | APEX1 | |
| SCHEMBL15267971 | 0.62 | APEX1 (0.40) | APEX1TERT | |
| SCHEMBL329861 | 0.58 | HTR2C (0.38) | — | |
| SCHEMBL10612 | 0.55 | — | — | |
| SCHEMBL13590042 | 0.55 | PNMT (0.65) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210355265-A1 | TRANSPARENT TPU BLENDS WITH PYRROLIDONE-CONTAINING POLYAMIDES | BASF SE (DE) | 2021-11-18 | — | — | US | claimed |
| EP-3494153-B1 | TRANSPARENT TPU BLENDS WITH PYRROLIDONE CONTAINING POLYAMIDES | BASF SE (DE) | 2020-09-09 | — | — | EP | claimed |
| US-10745557-B2 | Polyamide mixtures comprising polyamides containing pyrrolidone | BASF SE (DE) | 2020-08-18 | — | — | US | claimed |
| EP-3420017-B1 | POLYAMIDE BLENDS HAVING POLYAMIDES CONTAINING PYRROLIDONE | BASF SE (DE) | 2019-12-18 | — | — | EP | claimed |
| US-20190048189-A1 | POLYAMIDE MIXTURES COMPRISING POLYAMIDES CONTAINING PYRROLIDONE | BASF SE (DE) | 2019-02-14 | — | — | US | claimed |
| US-20210355265-A1 | TRANSPARENT TPU BLENDS WITH PYRROLIDONE-CONTAINING POLYAMIDES | BASF SE (DE) | 2021-11-18 | — | — | US | disclosed |
| US-10745557-B2 | Polyamide mixtures comprising polyamides containing pyrrolidone | BASF SE (DE) | 2020-08-18 | — | — | US | disclosed |
| US-20190048189-A1 | POLYAMIDE MIXTURES COMPRISING POLYAMIDES CONTAINING PYRROLIDONE | BASF SE (DE) | 2019-02-14 | — | — | US | disclosed |
| EP-1767520-B1 | Hydrogenation of aromatic amines to alicyclic amines using a ruthenium catalyst supported on lithium aluminate | AIR PROD & CHEM (US) | 2011-06-08 | — | — | EP | disclosed |
| US-7465833-B2 | Hydrogenation of aromatic amines to alicyclic amines using a lithium aluminate-based catalyst | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2008-12-16 | — | — | US | disclosed |
| US-20080146768-A1 | PROCESSES FOR PREPARING POLYMERS USING ALPHA,OMEGA-DIFUNCTIONAL ALDARAMIDES | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-06-19 | — | — | US | disclosed |
| EP-1858955-A1 | PROCESSES USING ALPHA, OMEGA-DIFUNCTIONAL ALDARAMIDES AS MONOMERS AND CROSSLINKERS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2007-11-28 | — | — | EP | disclosed |
| EP-1767520-A1 | Hydrogenation of aromatic amines to alicyclic amines using a ruthenium catalyst supported on lithium aluminate | Air Products and Chemicals, Inc. (US) | 2007-03-28 | — | — | EP | disclosed |
| US-20070066849-A1 | Hydrogenation of aromatic amines to alicyclic amines using a lithium aluminate-based catalyst | EVONIK OPERATIONS GMBH (DE) | 2007-03-22 | — | — | US | disclosed |
| US-20060264672-A1 | Processes using alpha, omega-difunctional aldaramides as monomers and crosslinkers | E. I. DU PONT DE NEMOURS AND COMPANY | 2006-11-23 | — | — | US | disclosed |
| WO-2006091901-A1 | PROCESSES USING ALPHA, OMEGA-DIFUNCTIONAL ALDARAMIDES AS MONOMERS AND CROSSLINKERS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264672-A1 | Processes using alpha, omega-difunctional aldaramides as monomers and crosslinkers | ALOX5, GSTO1, FASN | APEX1 624/4885TERT 855/4885CHKA 405/4885 |
| US-20070066849-A1 | Hydrogenation of aromatic amines to alicyclic amines using a lithium aluminate-based catalyst | HRH3, HRH4, AAAS | APEX1 618/4885TERT 1174/4885CHKA 744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.